Last reviewed · How we verify
NCT05183061
Factors Associated With Post-induction Hypotension in iNPH Patient Undergoing VP and LP Shunt
trial testing Ehedrine Norepineprine in The iNPH Patients Scheduled for VP or LP Shunt Procedures in 426 participants. Completed in 20 December 2021.
30 November 2021
Quick facts
| Lead sponsor | Mahidol University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 426 |
| Start date | 1 June 2021 |
| Primary completion | 30 November 2021 |
| Estimated completion | 20 December 2021 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Ehedrine Norepineprine — full drug profile →
Conditions studied
- The iNPH Patients Scheduled for VP or LP Shunt Procedures — all drugs for The iNPH Patients Scheduled for VP or LP Shunt Procedures →
Sponsor
Mahidol University
Who can join
18 and older, any sex, with The iNPH Patients Scheduled for VP or LP Shunt Procedures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a retrospective work involving the review of patients who were scheduled for VP or LP shunt in Siriraj Hospital, Mahidol University, Thailand. The sample size calculation was based on the rule of thumbs of the logistic regression comprising 18 risk factors. The incidence of post-induction hypotension according to our institution's pilot study November 2019-January 2020) was 47%. With 10% addition for missing data and other possible reasons, the sample size was 426. The primary objective of the study is to report the factors associated with post-induction hypotension in iNPH patients undergoing VP or LP shunt procedures. Our secondary objective is to determine the incidence of post-induction hypotension in these patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05183061
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Mahidol University trials
Trials by the same sponsor.
- NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
- NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
- NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
- NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
- NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05183061 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mahidol University
- Last refreshed: 10 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05183061.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing